Rodman & Renshaw downgrades Poniard Pharmaceuticals Inc. (Nasdaq: PARD) to Market Perform.

Rodman ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE